The Dutch version of the McLean Screening Instrument for borderline personality disorder (MSI-BPD)

Objective: Borderline personality disorder is a severe and disabling condition, with suicide rates up to 10%. A simple and valid screening instrument for borderline symptomatology would be of great use. Method: We translated the McLean Screening Instrument for borderline personality disorder (MSI-BPD) in Dutch and present initial validation data from a sample of 459 (mostly female) undergraduates. Results: Principal component analysis indicated that a single component underlies variability in the 10 items of the MSI-BPD. Internal consistency was adequate (alpha=.76), and test-retest reliabilit... Mehr ...

Verfasser: Verschuere, Bruno
Tibboel, Helen
Dokumenttyp: journalarticle
Erscheinungsdatum: 2011
Schlagwörter: Social Sciences / VALIDITY / DIAGNOSIS / PREVALENCE / DEPRESSION / RELIABILITY
Sprache: Niederländisch
Permalink: https://search.fid-benelux.de/Record/base-27063113
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://biblio.ugent.be/publication/2098246

Objective: Borderline personality disorder is a severe and disabling condition, with suicide rates up to 10%. A simple and valid screening instrument for borderline symptomatology would be of great use. Method: We translated the McLean Screening Instrument for borderline personality disorder (MSI-BPD) in Dutch and present initial validation data from a sample of 459 (mostly female) undergraduates. Results: Principal component analysis indicated that a single component underlies variability in the 10 items of the MSI-BPD. Internal consistency was adequate (alpha=.76), and test-retest reliability in a subsample as high (ca 4 months: r=.80). Females scored significantly higher than males. Finally, the MSI-BPD correlated strongly (r=.62) with depression as assessed by the BDI-II-NL. Conclusions: These data provide initial support for the reliability and the validity of the Dutch MSI-BPD, yet application in clinical practice requires information on the diagnostic agreement with a validated structured clinical interview.